pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-125b-2 |
Genomic Coordinates | chr21: 16590237 - 16590325 |
Synonyms | MIRN125B2, MIR125B2 |
Description | Homo sapiens miR-125b-2 stem-loop |
Comment | This miRNA sequence is predicted based on homology to a verified miRNA from mouse . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-125b-2-3p | ||||||||||||||
Sequence | 54| UCACAAGUCAGGCUCUUGGGAC |75 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Cloned | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TNRC6C | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | trinucleotide repeat containing 6C | ||||||||||||||||||||
Transcript | NM_001142640 | ||||||||||||||||||||
Other Transcripts | NM_018996 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TNRC6C | |||||||||||||||||||||
3'UTR of TNRC6C (miRNA target sites are highlighted) |
>TNRC6C|NM_001142640|3'UTR 1 GCTCTGCCATCATCAGCACCAGGAGAGCCGACCCCTCCCGGGACCCCTCCCGGCTGGGCGGCCCCACAGACCCGCTGGAA 81 CCCAGCAGCGGCCGCCCTTTTGAGTACCTCTGTCCAGGACTGAAGACGAACCTTGGCCGCAGTCCTTGCGAACTGTTCGC 161 AAAACAGTGCGGGCTGCGGTGGGTCAGCGTCACATGCTAATGACAGGATGTTCCTCGTAGCTTTTTATTTTGTGCGTCTT 241 ATGTTTGTATAGTGTGTTGTCATTTTGATTTTTTTTTTTTTTTTAAGTATAAAAGCTGCTTAGAATAGTTCTATCATGAA 321 GGGCACTTTTCAGATTGTGGGCTGGAAAGGGTTATTTTATCTGTGGGGGAGGGAGGGAGACGTGAAGCCTATTTAAAATG 401 AGCCTGTGACGATTATGCACATGACCAGAGGCGGCCGGTAATCAGGGCAGAGTCTGGTGTGGACCGCCGGGCGCAGAGCG 481 GCTCCGCGGCGGGAGCTGAGCGGAAGGCGCGGGCTGCGATCTGCTCTCTGTTCCCCTGGATCCGCCTATGCACATTACCC 561 TTGTTTCATTACTTTTTCATGTCATTTTTTTATCCCAAAAAATATTTTTTAAAAGTTAAAAAAAGACATATCAAACATGC 641 AAATACTTGAATCCAGCAGGCCAATAGTGAAATGTGAACACTTTCTAATTCTACACTTCCAGGTTGACATCAGTACACAG 721 AAACAGGCTCTAGGAAAAATTTCTAAGTTCATAGCCTACGTGTGTGTATGTGTGCGTGTTGAAACAGAAGTGTGTGTGTG 801 TGTGCATGTGTGGCGCGTGCTCCTGCACGGCGTGCAGTTTTCTGTGTTTGTGTGTTTGAAAGCGTGTGAGGATTTAACTG 881 TGGGTTTTCCCTTGTATTCAGTATACGCTTTTTTTTTGGCGCATTGGTCAAACGGTTGTTATTATTAGCTTCTAACTTTG 961 CACTGAGTGTCCTCGCCCTTCCTTTAGCTAATCCTATACATTACAGAGAATTCCTAGGACAGGGCTGGCGACAATTCATG 1041 TGTAAATGTTTACTCAAGGACTCTGTGACTGCGTTTAAAAAGTACAGTGTATATCTCTGGAGAAATAACATGTATACCTA 1121 CCTTTAGCAGCTTTTTATTGTGGACTAATGCAAGAAAATTATTACCAGAGTATTGCACCATTTTTCCATTTGGAATATAA 1201 AGTTAAAGAGAAAAAAAAAAAAAACTGTTGTTGAACTGTGGCCATAGATACTTGTAAAGAATGGATGGTTCCGTGGAAGG 1281 AACAGAAACAAGCACTTGGGCGTGGGTTGTGACTGCTTTTGGGGGAGCCTGGGGTTTGGGCTCCCACCTGTTTACAGACC 1361 TTTTTTTCTCCTTCAGACTTTAAAATTTTAAAAATTTAAAAAGGAATTAAAAAAAAAAAAAGACTTCCGTCGTAAAGAAA 1441 CCTATTTTCAGAATGCAGATGCGTTCCTTCAGAGCTCTGGGACGGGACAGTGTTGTTCCCTCGGCCATCGTCGTGGACTC 1521 TGTCGATTGCTTTCGCCCCTTCGTCAAGGTGACAGGCGTTGTGGCCACTGTCTTGCACATGCCGGACGCGCTCTCAGGAA 1601 AGCCAGGGCTCCCGAGGGCAGCTCCACACCATTTCATGTATTTTTAAACCCAACTCCTAGCACTGAAGATGTTATTTAAA 1681 AAAAAAAAAAACAAAACAAAACAAAAAAATGAAAAAAAAGAAAAAGAGGAAAAAAAAACACAAAGAAGAAAAATACCTAA 1761 TCTCTAATGTGTAGCAGTTACATATTTACCAAATAATGGACTCAAAAGAAATAGATGTTTGAAGAGTGCTTTATATATTA 1841 AAAATTGCTTTATGTTTTAAAAATGATCAATGTTTTGATTGTTTTGCAAGGAAGAAAGACAATGGAATAACATACCTTCA 1921 AGTATGTTTTAAAAAATATATATATGAACATTGTGCTCCCTGCCTGCTTGATCAGGAAACTTGTGCATTACATTTTTTTA 2001 ATTAGCTTTTTAATGGTTTTATCAAAACAAAAAAAATACAAAAAAAAAAAAAAAAGTCCTGCAAGACTGCAGATCCACAA 2081 AAGCTGGTTTTATAGAGGATCATGAACTATGCACAAACTGGGTTCAAGACTTTTTTTCTCAAGTTTAGTAGGATATTTAG 2161 AAAAACCAACCTTCCTCAGAGTGACTGCATCTCATTGCCATTACATGCGTTCTATATATTCGATGGACATACACCTGCGT 2241 ATGTATATCCAATATGTGTGCGTGTGAGCATGCGTGTGCGTATGTGCGTCCGACATACCACTTCCCGTGCTGCCGGCGAG 2321 CATTGAGTTGTAGAAAAACTGTTGTTTTAAAATTGGGGATGGAAGTCAAGAATATGTTTGTTTGTTTTTGGGTTTTGTTG 2401 GGTTTGAGGGGTTTTTTGTTTGTTTGTTTTTTGTTTTTTTTACCTTTTATTTTGAACTTAATATGTCTGTAACTCTGAGA 2481 TTAAACAACAAGTTCGTGGCTCTTAATGTTTTCCTCATAGAATGTGACTGTTGAAGAACATGCATCGAAAGTTGCTTTCG 2561 AAAGTACAACGCTTTATTGAATCTTAATAAATTGCAATTTTTTTCTTGGCTGTTCAAAGTAATGTGTTTTTCATTTTTCA 2641 AAAGACACTATGGATGTCTACTTTGCACGCTGCGATTGGGAGAGCTGTCCCGCTGCATGCGTTCCCTCTGTAATTTCCTC 2721 AGAGCTCACATACGTACCTCTCTCACGAGTGAACTCAGATTTTCCATTGTTTTGCTTTATTCTATCATTTGCTTTGTGGT 2801 TTTGCTGTAAATATTGAAATCTTAATCATCATCGAGAGGCACAGCCAAGCTTTCCAGCTCTCCACCCCCGTGGCCCATCC 2881 AAGTCTGTTCATCTGGTAACTTCTGTTGTCTGGGACGGCAGCAAGAAGATGCCGGGGCTTGCCTGGAGTCCTGGCAGAGG 2961 AGTGCCACTCACTTTTGCCTAGGGTCCAGTTGGGGCTTAAAAAATATTTGGAGAGAAGAGTAATGAGGATTTTTTGTGTT 3041 TCCTAGACATTTTATGCATCTATTTTTGTAAAATCACCTTCGCTAACTTTCACCAAGCACTTTGAGCACAGTGGAACTTC 3121 AGAAGCACAACCAGCCTAACCCCAGAATCTCAGGTGGCACAGCTAGAAATTGAGTCCCTTCCTAGGACACTGGCCGTGGC 3201 CTTCAGGGTGACCAGTCAGTGCCACCGGGTTGGCATTGGTGTTACAGACAGGCCTCTGAAGACAAACCGAGCACCCCAGC 3281 GGCCCCTCAAACTAAGCAAGGATCTTTTTTCTGTCTGCGCTCCCTGGGGCAAGGTCAAAGGTGGACCCGCCCACTGTGGG 3361 TCAATTCCTTCGAAAAGATGGGACCCGCACCCCCGCCACAGGCTGGCCCCCCCCCACCCATGGGGAAGGTGGTGTGCTGC 3441 TGGCTCTGACCATACTCTTTTGGAAATTGAGAAGGAAAGCATTGAGTGGGACCTAATCCGGAGAAGAAATTAAAGACCAG 3521 AAAAAGAAGGAAGCTGGGAATGAAACTCAAAATGCACTTGAACCTGGAAGCGGCAACCCTCAGCTCTGCGCGGCCGAGCC 3601 TCAGCAAGAGTTCGTTTTGTGCCTGAGTTACTACTACAGGGGCAAACTGTACCCGTGCCTGTGCGCTGGGAGAACAAGGT 3681 CAGCGCCCAAGGGTGTGCAAAGGATGTGGCAGGCTTCATGGAGGAGGTGGCATTTGCCCTGGGCCTGGGAGACCAGGTTG 3761 GATTTTGACAGACTGGGAACTCGGGGGACAGGAGGGCAGCACAGTGTAAGCTAAAGCCCTGTGTAGGGACCCCACGCAAA 3841 GACCTCGTGGGCCTGGGTGTCCAGGGCACCATTTCCACCCATGGGTGAAAAAGAGGCTTGAGGAAGACAACAGGTTCTTC 3921 ACCTGCATCTGTGGATATATATTTTTTTAAGTTTATTAAATTTTTTTTTAAATGGCAGTTTCAGACCTGCAAAAAAAAAA 4001 AAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 57690.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000335749.4 | 3UTR | AAACUUGUGCAUUACAUUUUUUUAAUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000335749.4 | 3UTR | AAACUUGUGCAUUACAUUUUUUUAAUUAGCUUUUUAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000335749.4 | 3UTR | AACUUGUGCAUUACAUUUUUUUAAUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
91 hsa-miR-125b-2-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038624 | HN1L | Jupiter microtubule associated homolog 2 | 1 | 1 | ||||||||
MIRT038625 | KDELC2 | KDEL motif containing 2 | 1 | 1 | ||||||||
MIRT038626 | ABHD15 | abhydrolase domain containing 15 | 1 | 1 | ||||||||
MIRT038627 | PPP1R12C | protein phosphatase 1 regulatory subunit 12C | 1 | 1 | ||||||||
MIRT038628 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 1 | 1 | ||||||||
MIRT038629 | ASH2L | ASH2 like histone lysine methyltransferase complex subunit | 1 | 1 | ||||||||
MIRT038630 | USP22 | ubiquitin specific peptidase 22 | 1 | 1 | ||||||||
MIRT038631 | CSTB | cystatin B | 1 | 1 | ||||||||
MIRT038632 | SYT2 | synaptotagmin 2 | 1 | 1 | ||||||||
MIRT038633 | NDUFS7 | NADH:ubiquinone oxidoreductase core subunit S7 | 1 | 1 | ||||||||
MIRT038634 | MTA2 | metastasis associated 1 family member 2 | 1 | 1 | ||||||||
MIRT053086 | IGF1R | insulin like growth factor 1 receptor | 3 | 1 | ||||||||
MIRT055788 | PLEKHA1 | pleckstrin homology domain containing A1 | 2 | 12 | ||||||||
MIRT061248 | AMOTL1 | angiomotin like 1 | 2 | 10 | ||||||||
MIRT061649 | BTG2 | BTG anti-proliferation factor 2 | 2 | 6 | ||||||||
MIRT079046 | TNRC6C | trinucleotide repeat containing 6C | 2 | 4 | ||||||||
MIRT084583 | BCL2L11 | BCL2 like 11 | 2 | 8 | ||||||||
MIRT093523 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | 2 | 2 | ||||||||
MIRT097383 | LHFPL2 | LHFPL tetraspan subfamily member 2 | 2 | 4 | ||||||||
MIRT098030 | SOBP | sine oculis binding protein homolog | 2 | 2 | ||||||||
MIRT186262 | TCEB3 | elongin A | 2 | 2 | ||||||||
MIRT187284 | DAZAP2 | DAZ associated protein 2 | 2 | 10 | ||||||||
MIRT361113 | LRRC1 | leucine rich repeat containing 1 | 2 | 2 | ||||||||
MIRT443585 | FAM84B | family with sequence similarity 84 member B | 2 | 2 | ||||||||
MIRT452249 | TRAM1 | translocation associated membrane protein 1 | 2 | 2 | ||||||||
MIRT476289 | GMFB | glia maturation factor beta | 2 | 8 | ||||||||
MIRT483871 | MRPL12 | mitochondrial ribosomal protein L12 | 2 | 2 | ||||||||
MIRT484250 | ANK1 | ankyrin 1 | 2 | 2 | ||||||||
MIRT499251 | VAV3 | vav guanine nucleotide exchange factor 3 | 2 | 4 | ||||||||
MIRT502270 | HNRNPA1 | heterogeneous nuclear ribonucleoprotein A1 | 2 | 4 | ||||||||
MIRT504652 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT505210 | UBN2 | ubinuclein 2 | 2 | 6 | ||||||||
MIRT512690 | POP1 | POP1 homolog, ribonuclease P/MRP subunit | 2 | 2 | ||||||||
MIRT517341 | ZNF529 | zinc finger protein 529 | 2 | 4 | ||||||||
MIRT518946 | LSG1 | large 60S subunit nuclear export GTPase 1 | 2 | 2 | ||||||||
MIRT520866 | SUGT1 | SGT1 homolog, MIS12 kinetochore complex assembly cochaperone | 2 | 2 | ||||||||
MIRT521236 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT528324 | GIGYF2 | GRB10 interacting GYF protein 2 | 2 | 2 | ||||||||
MIRT533297 | USP46 | ubiquitin specific peptidase 46 | 2 | 2 | ||||||||
MIRT541024 | WEE1 | WEE1 G2 checkpoint kinase | 2 | 4 | ||||||||
MIRT544034 | ERRFI1 | ERBB receptor feedback inhibitor 1 | 2 | 2 | ||||||||
MIRT547037 | POGZ | pogo transposable element derived with ZNF domain | 2 | 2 | ||||||||
MIRT556102 | MOAP1 | modulator of apoptosis 1 | 2 | 2 | ||||||||
MIRT558320 | DR1 | down-regulator of transcription 1 | 2 | 2 | ||||||||
MIRT558520 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT566230 | PTMA | prothymosin, alpha | 2 | 4 | ||||||||
MIRT568437 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT570584 | OTUD7B | OTU deubiquitinase 7B | 2 | 2 | ||||||||
MIRT571384 | JKAMP | JNK1/MAPK8-associated membrane protein | 2 | 2 | ||||||||
MIRT572798 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT573864 | C9orf78 | chromosome 9 open reading frame 78 | 2 | 2 | ||||||||
MIRT609930 | SLC38A1 | solute carrier family 38 member 1 | 2 | 4 | ||||||||
MIRT610437 | CSMD2 | CUB and Sushi multiple domains 2 | 2 | 2 | ||||||||
MIRT614407 | MURC | caveolae associated protein 4 | 2 | 2 | ||||||||
MIRT618625 | GREB1 | growth regulation by estrogen in breast cancer 1 | 2 | 2 | ||||||||
MIRT620605 | SAP30 | Sin3A associated protein 30 | 2 | 2 | ||||||||
MIRT635313 | FAM179A | TOG array regulator of axonemal microtubules 2 | 2 | 2 | ||||||||
MIRT635918 | GLTSCR2 | NOP53 ribosome biogenesis factor | 2 | 2 | ||||||||
MIRT638507 | MAP3K9 | mitogen-activated protein kinase kinase kinase 9 | 2 | 2 | ||||||||
MIRT640597 | TM9SF4 | transmembrane 9 superfamily member 4 | 2 | 2 | ||||||||
MIRT644066 | IQCE | IQ motif containing E | 2 | 2 | ||||||||
MIRT648287 | TRAPPC2L | trafficking protein particle complex 2 like | 2 | 2 | ||||||||
MIRT653089 | SSR3 | signal sequence receptor subunit 3 | 2 | 2 | ||||||||
MIRT654651 | PTAFR | platelet activating factor receptor | 2 | 2 | ||||||||
MIRT658084 | FOXR2 | forkhead box R2 | 2 | 2 | ||||||||
MIRT665306 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT665974 | SYTL4 | synaptotagmin like 4 | 2 | 2 | ||||||||
MIRT674905 | RASSF9 | Ras association domain family member 9 | 2 | 2 | ||||||||
MIRT680085 | THAP1 | THAP domain containing 1 | 2 | 2 | ||||||||
MIRT681487 | DIP2A | disco interacting protein 2 homolog A | 2 | 2 | ||||||||
MIRT691243 | DFNB59 | pejvakin | 2 | 2 | ||||||||
MIRT692361 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT693034 | MB21D1 | Mab-21 domain containing 1 | 2 | 2 | ||||||||
MIRT694478 | LRTOMT | leucine rich transmembrane and O-methyltransferase domain containing | 2 | 2 | ||||||||
MIRT696069 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT696579 | TTC21B | tetratricopeptide repeat domain 21B | 2 | 2 | ||||||||
MIRT696759 | MTFMT | mitochondrial methionyl-tRNA formyltransferase | 2 | 2 | ||||||||
MIRT697306 | ZNF652 | zinc finger protein 652 | 2 | 2 | ||||||||
MIRT698736 | STX12 | syntaxin 12 | 2 | 2 | ||||||||
MIRT701055 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT701197 | OTUD3 | OTU deubiquitinase 3 | 2 | 2 | ||||||||
MIRT701334 | NSD1 | nuclear receptor binding SET domain protein 1 | 2 | 2 | ||||||||
MIRT703617 | FBXO45 | F-box protein 45 | 2 | 2 | ||||||||
MIRT708893 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT711621 | DGKH | diacylglycerol kinase eta | 2 | 2 | ||||||||
MIRT713744 | TMEM81 | transmembrane protein 81 | 2 | 2 | ||||||||
MIRT715060 | TMTC1 | transmembrane and tetratricopeptide repeat containing 1 | 2 | 2 | ||||||||
MIRT719711 | CD101 | CD101 molecule | 2 | 2 | ||||||||
MIRT720293 | DLGAP3 | DLG associated protein 3 | 2 | 2 | ||||||||
MIRT722605 | CCDC152 | coiled-coil domain containing 152 | 2 | 2 | ||||||||
MIRT724565 | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|